Four finalists for The Venture Forum’s 2013 Business Plan Contest were selected in a rigorous round of presentations and judging on October 5th. The finalists will polish their business case presentations and present them to a panel of venture capital professionals and the general audience at the Business Plan ContestNovember 12th at Worcester Polytechnic Institute. The winner will be awarded a cash and “in kind” package valued at over $10,000.
The finalists are Cocoon Biotech, Energy Harvesters, Phonologics Inc., and Standard Genetics. Here is some additional information about the finalists:
Cocoon Biotech’s injectable biomaterial will revolutionize the treatment of osteoarthritis (OA) by providing extended joint pain relief. OA currently impacts 27 million US adults and will reach 65 million by 2030. The disease manifests as pain, inflammation, and reduced mobility leading to decreased quality of life. Current intra-articular injections viscosupplementation and steroids) aimed to alleviate joint pain are marginally effective, short lasting, produce localized inflammation, and require multiple injections.
Energy Harvesters is commercializing a personal electronics mobile power source. This off-the-grid device will charge portable electronic device batteries as you walk or directly power applications such as footwear heaters and GPS locators without the need for batteries. The Walking Charger™ is a small device that will be incorporated within footwear for OEM branded products serving military, recreation, work boot and consumer end users.
A Software-as-a-Service (SaaS) firm in the global business of computer-based spoken English intelligibility assessment. Intelligibility refers to the ability of a non-native speaker of English to be understood by a native speaker of English. The proprietary cloud-based scoring engine of Phonologics’ Automated Pronunciation Screening Test (APST) produces a robust, immediate and actionable assessment with report, based on a software app that prompts the test-taker to speak specific words and sentences into a local client computer. Unlike the traditional “human-listener” approach to assessment, APST is fast, validated, economical, highly scalable -- and objective.
Standard Genetics is a company that creates standardized diagnostic assays for the application in molecular medicine, providing education-based meaningful information, to both doctor and patient, on the outcome of the results, which leads to improved patient care and the delivery of the right therapeutic treatment.